Rituximab reduction for pediatric advanced-stage Burkitt lymphoma

被引：0
|
作者：
Valiev, T. [1 ]
Popa, A. [1 ]
Mentkevich, G. [1 ]
机构：
[1] Minist Hlth Russian Federat, NN Blokhin Natl Canc Res Ctr, Pediat Oncol & Hematol Res Inst, Moscow, Russia
来源：
LEUKEMIA RESEARCH | 2019年 / 85卷
关键词：
D O I：
10.1016/S0145-2126(19)30269-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OP-26
引用
收藏
页码：S30 / S30
页数：1
相关论文
共 50 条
  • [21] Advanced-Stage Follicular Lymphoma in the Rituximab Era When Should Patients Receive Anthracycline-Based Chemotherapy?
    Pettengell, Ruth
    DRUGS, 2009, 69 (13) : 1727 - 1737
  • [22] Rituximab in a child with relapsed Burkitt lymphoma
    Bay, Ali
    Dogan, Murat
    Acikgoz, Mehmet
    Oner, Ahmet Faik
    PEDIATRIC BLOOD & CANCER, 2007, 49 (02) : 218 - 218
  • [23] Outcomes of adolescents and young adults with advanced stage Burkitt lymphoma
    Valiev, T.
    Semionova, A.
    Zejnalova, P.
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 182 : 77 - 77
  • [24] Incomplete Miller Fisher Syndrome with Advanced Stage Burkitt Lymphoma
    Ozdemir, Zeynep Canan
    Kar, Yeter Duzenli
    Yarar, Copkun
    Paylysoy, Suzan
    Bor, Ozcan
    INDIAN PEDIATRICS, 2017, 54 (05) : 413 - 415
  • [25] Incomplete Miller—Fisher syndrome with advanced stage Burkitt lymphoma
    Özdemir Z.C.
    Kar Y.D.
    Yarar C.
    Þaylýsoy S.
    Bör Ö.
    Indian Pediatrics, 2017, 54 (5) : 413 - 415
  • [26] Long-term survey of 443 cases of advanced-stage follicular lymphoma in Japan during the rituximab era.
    Hirayama, Yasuo
    Ishitani, Kunihiko
    Ohta, Shuithi
    Kurosawa, Mitsutoshi
    Kondo, Takeshi
    Takimoto, Rishu
    Kato, Junji
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [27] Clinical Factors Impact on Pharmacokinetics of CT-P10 and Reference Rituximab in Patients with Advanced-Stage Follicular Lymphoma
    Kim, Won Seog
    Coiffier, Bertrand
    Buske, Christian
    Ogura, Michinori
    Kwak, Larry W.
    Lee, SangJoon
    Bae, YunJu
    Kim, SuYoung
    Kim, MinJu
    Lee, SangMi
    Lee, Dahye Kwakand HyunJin
    BLOOD, 2017, 130
  • [28] Watchful Waiting As Initial Management of Advanced-Stage Follicular Lymphoma in the Rituximab Era: Analysis of the National Cancer Data Base
    Fallah, Jaleh
    Thomas, Anthony G.
    Olszewski, Adam J.
    BLOOD, 2015, 126 (23)
  • [29] Introduction of rituximab in front-line and salvage therapies has improved outcome of advanced-stage follicular lymphoma patients
    Sacchi, Stefano
    Pozzi, Samantha
    Marcheselli, Luigi
    Bari, Alessia
    Luminari, Stefano
    Angrilli, Francesco
    Merli, Francesco
    Vallisa, Daniele
    Baldini, Luca
    Brugiatelli, Maural
    CANCER, 2007, 109 (10) : 2077 - 2082
  • [30] A plus AVD versus eBEACOPP in advanced-stage Hodgkin lymphoma
    Diehl, Louis F.
    LANCET HAEMATOLOGY, 2021, 8 (06): : E384 - E386
12345